Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P860057/S225

Carpentier-Edwards PERIMOUNT Magna Ease Aortic Heart Valve, Carpentier-Edwards PERIMOUNT Magna Mitral Ease Bioprosthesis

Edwards Lifesciences, LLC · Decision date Apr 16, 2026

FDA DECISIONP860057/S225

What did the FDA decide?

FDA records P860057/S225 as a supplement to PMA P860057, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Apr 16, 2026.

FDA approval order statement

an alternative method to process devices prior to RESILIA treatment, and cleanroom modifications to accommodate this alternative processing method
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Apr 16, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P860057/S225
Regulatory pathway
PMA supplement
Product code
DYE
Decision code
OK30
Decision date
Apr 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: replacement Heart-valve.

Product code
DYE
FDA device class
3

For the original device and its historical approval scope, see PMA P860057. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P860057 · Original PMA

    EDWARDS LIFESCIENCES PERIMOUNT AORTIC AND MITRAL BIOPROSTHESES

  2. P860057/S223 · Related supplement

    Carpentier-Edwards PERIMOUNT RSR Pericardial Aortic Bioprosthesis; Carpentier-Edwards PERIMOUNT Plus Mitral Bioprosthesi

  3. P860057/S224 · Related supplement

    Carpentier-Edwards PERIMOUNT Theon RSR Pericardial Aortic Bioprosthesis with ThermaFix tissue process; Carpentier-Edwar

  4. P860057/S225 received

    Application receipt date recorded by FDA.

  5. P860057/S225 · FDA decision

    30-Day Notice

  6. P860057/S226 · Related supplement

    Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Aortic Bioprosthesis

  7. P860057/S227 · Related supplement

    Carpentier-Edwards PERIMOUNT RSR Pericardial Aortic Bioprosthesis Model 2800; Carpentier-Edwards PERIMOUNT RSR Pericardi

  8. P860057/S228 · Related supplement

    Carpentier-Edwards PERIMOUNT Theon RSR Pericardial Aortic Bioprosthesis with ThermaFix tissue process (2800TFX), Carpen

Timeline entries are records held by MedtechLedger for P860057. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P860057

Explore the linked device profile

Other records with product code DYE

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic, Inc.PMA supplementMar 3, 2026FDA
Medtronic, Inc.PMA supplementFeb 12, 2026FDA
Medtronic, Inc.PMA supplementFeb 12, 2026FDA
Medtronic, Inc.PMA supplementNov 10, 2025FDA
Medtronic, Inc.PMA supplementNov 10, 2025FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Edwards Lifesciences, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
One Edwards Way, Irvine, CA, 92614

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records